Luminor Medical Technologies

Luminor Medical Technologies was a Canadian public life sciences company focused primarily on non-invasive diagnostic technologies and, later, cannabis-based consumer health formulations. The company was formerly known as Miraculins and developed or commercialized products including the Scout DS diabetes screening device, the PREVU Skin Cholesterol Test, and PSP94-based diagnostic assets, while also advancing diagnostic programs in cardiovascular disease, preeclampsia, and several cancers. In late 2017, the company added Jamaica BLU Limited and cannabis formulation rights associated with Rise Research. In March 2018, Luminor changed its corporate name to RISE Life Science Corp., meaning Luminor Medical Technologies is best understood as a historical company name rather than an independently active current operating entity. For biotech and healthcare diligence, it is most accurately characterized as a small-cap Canadian diagnostics company that pivoted into cannabis health products before being renamed.